00

YanAn Bicon Pharmaceutical Listed CoSHE 002411 Stock Report

Last reporting period 31 Mar, 2023

Updated —

Last price

Market cap $B

0.135

Micro

Exchange

XSHE - Shenzhen Stock Exchange

002411.SZ Stock Analysis

00

Uncovered

YanAn Bicon Pharmaceutical Listed Co is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-32/100

Low score

Market cap $B

0.135

Dividend yield

Shares outstanding

1 532.28 B

YanAn Bicon Pharmaceutical Listed Co. engages in the research and development, production and sales of pharmaceutical intermediate and nitrogen fertilizer products. The company is headquartered in Xi'An, Shaanxi and currently employs 4,078 full-time employees. The company went IPO on 2010-05-25. The firm operates its businesses through three segments. The Pharmaceuticals segment provides circulatory system, digestive system, respiratory system, nervous system and ophthalmic products. The New Materials segment mainly consists of lithium hexafluorophosphate, high-strength and high modulus polyethylene fibers and others. The Pharmaceutical Intermediates segment consists of 7-ADCA, benzaldehyde, 5.5-dimethylhydantion and trichloropyridine. The firm distributes its products mainly in domestic market.

View Section: Eyestock Rating